Disclosure under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) The details of schedule of Institutional investor(s) / Analysts meeting(s) /call(s) held on November 6, 2020 in Mumbai is attached herewith.
Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the management of the Company had a con-call with Investors and Analysts on November 6, 2020. Please find enclosed the schedule of Investor and Analyst Meet. Kindly take the above on your records and oblige.
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith the transcript of the Earnings Call held on Tuesday, November 03, 2020 at 12.00 Noon local time, post declaration of the Company's unaudited financial results (Stand-alone and Consolidated) for Quarter / Half Year ended September 30, 2020. This transcript is also made available at our website. Dr. A. Velumani, Chairman & Managing Director, Mr. Arindam Haldar, CEO, Mr. A. Sundararaju, CFO & Executive Director, Mr. Sachin Salvi, Vice-President- Finance, represented the Company.
In Compliance with Regulation 30 read with Schedule Ill of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we inform you that a Conference Call with Investors and Analysts is scheduled to be held on Wednesday, 11th November, 2020 at 04:15 PM to discuss the Financial Results for the Second Quarter ended 30th September,2020. Further details in this regard are posted on the Company's website under the Investor relation section.
